首页> 美国卫生研究院文献>Stem Cells International >Stem Cells for Cardiac Repair: Status Mechanisms and New Strategies
【2h】

Stem Cells for Cardiac Repair: Status Mechanisms and New Strategies

机译:用于心脏修复的干细胞:状态机制和新策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Faced with the end stage of heart disease, the current treatments only slow worsening of heart failure. Stem cells have the potential of self-renewal and differentiation. It is expected to replace and repair damaged myocardium. But many clinical trials have shown that the stem cell therapy of heart failure is modest or not effective. The possible causes for the limited effects of stem cell in curing heart failure are the stem cells which have been transplanted into the ischemic heart muscle may suffer low survival rate, affected by inflammatory molecules, proapoptotic factor, and lack of nutrients and oxygen, and then the stem cells which home and have been completely transplanted to the site of myocardial infarction become very small. Therefore, through preconditioning of stem cells and appropriate choice of genes for mesenchymal stem cell modification to improve the survival rate of stem cells, ability in homing and promoting angiogenesis may become the newly effective strategies for the application of stem cells therapy in heart failure.
机译:面对心脏病的末期,目前的治疗方法只能减缓心力衰竭的恶化。干细胞具有自我更新和分化的潜力。有望更换和修复受损的心肌。但是许多临床试验表明,干细胞治疗心力衰竭是适度的或无效的。干细胞在治愈心力衰竭中作用有限的可能原因是,已移植到缺血性心肌中的干细胞存活率低,受到炎症分子,促凋亡因子以及缺乏营养和氧气的影响,然后完全移植到心肌梗塞部位的干细胞变得很小。因此,通过干细胞的预处理和间充质干细胞修饰基因的适当选择以提高干细胞的存活率,归巢和促进血管生成的能力可能成为干细胞疗法在心力衰竭中应用的新有效策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号